<DOC>
	<DOCNO>NCT00002336</DOCNO>
	<brief_summary>To determine whether clarithromycin safe effective preventing disseminate Mycobacterium avium Complex HIV-infected patient CD4 count &lt; = 100 cells/mm3 .</brief_summary>
	<brief_title>The Safety Effectiveness Clarithromycin Prevention Mycobacterium Avium Complex ( MAC ) Infection HIV-Infected Patients</brief_title>
	<detailed_description />
	<mesh_term>Infection</mesh_term>
	<mesh_term>Communicable Diseases</mesh_term>
	<mesh_term>HIV Infections</mesh_term>
	<mesh_term>Mycobacterium Infections</mesh_term>
	<mesh_term>Mycobacterium avium-intracellulare Infection</mesh_term>
	<mesh_term>Clarithromycin</mesh_term>
	<criteria>Inclusion Criteria Patients must : HIV infection . CD4 count &lt; = 100 cells/mm3 . No evidence MAC . Life expectancy least 6 month . Exclusion Criteria Concurrent Medication : Excluded : Certain restrict drug ( detail available ) . Patients follow prior condition exclude : History allergy hypersensitivity macrolides . Active substance abuse condition would affect study compliance .</criteria>
	<gender>All</gender>
	<minimum_age>12 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>February 2009</verification_date>
	<keyword>Mycobacterium avium-intracellular Infection</keyword>
	<keyword>Acquired Immunodeficiency Syndrome</keyword>
	<keyword>Clarithromycin</keyword>
</DOC>